Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers

Xu Chen; Xiaofei Huo; Zhe Wu; Jingjing Lu

doi:10.24920/003963

Your Location：

Home >

Browse articles >

Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers

Chinese Medical Sciences Journal Vol. 36, Issue 3, Pages: 196-203(2021)

REVIEW | Updated：2024-04-10

- Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers
- Affiliations：
  
  1. 1Department of Radiology, Beijing United Family Hospital, Beijing 100015, China
  2. 2Department of Radiology, Fushun Central Hospital, Fushun, Liaoning 113006, China
- Author bio：
  
  *Tel: 86-13501398521; E-mail: cjr.lujingjing@vip.163.com
- Funds：
- DOI：10.24920/003963
  CLC：
- Received：30 June 2021，
  
  Accepted：2021-8-24，
  
  Published：30 August 2021
- Accepted：
Scan QR Code
Xu Chen, Xiaofei Huo, Zhe Wu, et al. Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers[J]. Chinese medical sciences journal, 2021, 36(3): 196-203.
DOI：

Xu Chen, Xiaofei Huo, Zhe Wu, et al. Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers[J]. Chinese medical sciences journal, 2021, 36(3): 196-203. DOI： 10.24920/003963.

摘要

卵巢癌是世界范围内常见的三大妇科恶性肿瘤之一

但病死率居首位。近年来

许多医学及工程技术研究尝试将人工智能（artificial intelligence

AI）技术应用于卵巢癌诊治的多个临床场景中

在医学影像AI技术的开发与应用中取得了较为丰富的进展。AI相关的医学影像研究主要涉及计算机断层扫描、超声成像和磁共振成像。我们对AI在卵巢癌医学影像方面的已发表的研究进行了文献检索和回顾

从卵巢癌的影像诊断、病理分类

靶向活检引导以及预后预测四个方面深入分析了医学影像领域AI相关研究的最新进展

同时对其现状及存在的问题进行了相应阐述。

Abstract

Ovarian cancer is one of the three most common gynecological cancers in the world

and is regarded as a priority in terms of women’s cancer. In the past few years

many researchers have attempted to develop and apply artificial intelligence (AI) techniques to multiple clinical scenarios of ovarian cancer

especially in the field of medical imaging. AI-assisted imaging studies have involved computer tomography (CT)

ultrasonography (US)

and magnetic resonance imaging (MRI). In this review

we perform a literature search on the published studies that using AI techniques in the medical care of ovarian cancer

and bring up the advances in terms of four clinical aspects

including medical diagnosis

pathological classification

targeted biopsy guidance

and prognosis prediction. Meanwhile

current status and existing issues of the researches on AI application in ovarian cancer are discussed.

关键词

Keywords

references

Reid F . World Ovarian Cancer Coalition. World Ovarian Cancer Coalition Atlas 2020 . Global trends in incidence, mortality, and survival . Available from https://worldovariancancercoalition.org/wp-content/uploads/2020/10/2020-World-Ovarian-Cancer-Atlas_FINAL.pdf https://worldovariancancercoalition.org/wp-content/uploads/2020/10/2020-World-Ovarian-Cancer-Atlas_FINAL.pdf . Accessed June 2 , 2021 .

National Cancer Institute . Surveillance, Epidemiology, End Result program . SEER Cancer Statistics Review, 1975-2017 . Available from https://seer.cancer.gov/archive/csr/1975_2017/results_merged/sect_21_ovary.pdf. Released April 15, 2020. Accessed September 14, 2021. https://seer.cancer.gov/archive/csr/1975_2017/results_merged/sect_21_ovary.pdf https://seer.cancer.gov/archive/csr/1975_2017/results_merged/sect_21_ovary.pdf

Granter SR , Beck AH , Papke DJ . AlphaGo, deep learning, and the future of the human microscopist . Arch Pathol Lab Med 2017 ; 141 ( 5 ): 619 - 21 . doi: 10.5858/arpa.2016-0471-ED 1001-9294-36-3-196/arpa.2016-0471-ED . DOI: 10.5858/arpa.2016-0471-ED http://doi.org/10.5858/arpa.2016-0471-ED

Sone K , Toyohara Y , Taguchi A , et al . Application of artificial intelligence in gynecologic malignancies: a review . J Obstet Gynaecol Res 2021 ; 47 ( 8 ): 2577 - 85 . doi: 10.1111/jog.14818 1001-9294-36-3-196/jog.14818 . DOI: 10.1111/jog.14818 http://doi.org/10.1111/jog.14818 https://onlinelibrary.wiley.com/toc/14470756/47/8 https://onlinelibrary.wiley.com/toc/14470756/47/8

Wang X , Lu Z . Radiomics analysis of PET and CT components of (18) F-FDG PET/CT imaging for prediction of progression-free survival in advanced high-grade serous ovarian cancer . Front Oncol 2021 ; 11 : 638124 . doi: 10.3389/fonc.2021.638124 1001-9294-36-3-196/fonc.2021.638124 . DOI: 10.3389/fonc.2021.638124 http://doi.org/10.3389/fonc.2021.638124 https://www.frontiersin.org/articles/10.3389/fonc.2021.638124/full https://www.frontiersin.org/articles/10.3389/fonc.2021.638124/full

Foronda M . The AI revolution in cancer. Nature portfolio: milestone . Released December 10, 2020 ; accessed June 10, 2021. Available from https://www.nature.com/articles/d42859-020-00082-9. https://www.nature.com/articles/d42859-020-00082-9 https://www.nature.com/articles/d42859-020-00082-9

Panagiotou OA , Hogg LH , Hricak H , et al . Clinical application of computational methods in precision oncology: a review . JAMA Oncol 2020 ; 6 ( 8 ): 1282 - 6 . doi: 10.1001/jamaoncol.2020.1247 1001-9294-36-3-196/jamaoncol.2020.1247 . DOI: 10.1001/jamaoncol.2020.1247 http://doi.org/10.1001/jamaoncol.2020.1247

Wang R , Cai Y , Lee IK , et al . Evaluation of a convolutional neural network for ovarian tumor differentiation based on magnetic resonance imaging . Eur Radiol 2021 ; 31 ( 7 ): 4960 - 71 . doi: 10.1007/s00330-020-07266-x 1001-9294-36-3-196/s00330-020-07266-x . DOI: 10.1007/s00330-020-07266-x http://doi.org/10.1007/s00330-020-07266-x https://doi.org/10.1007/s00330-020-07266-x https://doi.org/10.1007/s00330-020-07266-x

Chang K , Beers AL , Bai HX , et al . Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement . Neuro Oncol 2019 ; 21 ( 11 ): 1412 - 2 . doi: 10.1093/neuonc/noz106 1001-9294-36-3-196/neuonc/noz106 . DOI: 10.1093/neuonc/noz106 http://doi.org/10.1093/neuonc/noz106 https://academic.oup.com/neuro-oncology/article/21/11/1412/5514498 https://academic.oup.com/neuro-oncology/article/21/11/1412/5514498

Papp L , Potsch N , Grahovac M , et al . Glioma survival prediction with combined analysis of in vivo (11)C-MET PET features, ex vivo features, and patient features by supervised machine learning . J Nucl Med 2018 ; 59 ( 6 ): 892 - 9 . doi: 10.2967/jnumed.117.202267 1001-9294-36-3-196/jnumed.117.202267 . DOI: 10.2967/jnumed.117.202267 http://doi.org/10.2967/jnumed.117.202267 http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.117.202267 http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.117.202267

Chang K , Bai HX , Zhou H , et al . Residual convolutional neural network for the determination of IDH status in low- and high-grade gliomas from MR imaging . Clin Cancer Res 2018 ; 24 ( 5 ): 1073 - 81 . doi: 10.1158/1078-0432.CCR-17-2236 1001-9294-36-3-196/1078-0432.CCR-17-2236 . DOI: 10.1158/1078-0432.CCR-17-2236 http://doi.org/10.1158/1078-0432.CCR-17-2236

Zhang X , Yan LF , Hu YC , et al . Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features . Oncotarget 2017 ; 8 ( 29 ): 47816 - 30 . doi: 10.18632/oncotarget.18001 1001-9294-36-3-196/oncotarget.18001 . DOI: 10.18632/oncotarget.18001 http://doi.org/10.18632/oncotarget.18001

Martinez-Mas J , Bueno-Crespo A , Khazendar S , et al . Evaluation of machine learning methods with fourier transform features for classifying ovarian tumors based on ultrasound images . PLoS One 2019 ; 14 ( 7 ): e219388 . doi: 10.1371/journal.pone.0219388 1001-9294-36-3-196/journal.pone.0219388 . DOI: 10.1371/journal.pone.0219388 http://doi.org/10.1371/journal.pone.0219388

Zhang L , Huang J , Liu L . Improved deep learning network based in combination with cost-sensitive learning for early detection of ovarian cancer in color ultrasound detecting system . J Med Syst 2019 ; 43 ( 8 ): 251 . doi: 10.1007/s10916-019-1356-8 1001-9294-36-3-196/s10916-019-1356-8 . DOI: 10.1007/s10916-019-1356-8 http://doi.org/10.1007/s10916-019-1356-8

Aramendia-Vidaurreta V , Cabeza R , Villanueva A , et al . Ultrasound image discrimination between benign and malignant adnexal masses based on a neural network approach . Ultrasound Med Biol 2016 ; 42 ( 3 ): 742 - 52 . doi: 10.1016/j.ultrasmedbio.2015.11.014 1001-9294-36-3-196/j.ultrasmedbio.2015.11.014 . DOI: 10.1016/j.ultrasmedbio.2015.11.014 http://doi.org/10.1016/j.ultrasmedbio.2015.11.014 https://linkinghub.elsevier.com/retrieve/pii/S030156291500678X https://linkinghub.elsevier.com/retrieve/pii/S030156291500678X

Yang B , Zhong J , Zhong J , et al . Development and validation of a radiomics nomogram based on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and clinicopathological factors to predict the survival outcomes of patients with non-small cell lung cancer . Front Oncol 2020 ; 10 : 1042 . doi: 10.3389/fonc.2020.01042 1001-9294-36-3-196/fonc.2020.01042 . DOI: 10.3389/fonc.2020.01042 http://doi.org/10.3389/fonc.2020.01042

Pi S , Cao R , Qiang JW , et al . Utility of DWI with quantitative ADC values in ovarian tumors: a meta-analysis of diagnostic test performance . Acta Radiol 2018 ; 59 ( 11 ): 1386 - 94 . doi: 10.1177/0284185118759708 1001-9294-36-3-196/0284185118759708 . DOI: 10.1177/0284185118759708 http://doi.org/10.1177/0284185118759708 http://journals.sagepub.com/doi/10.1177/0284185118759708 http://journals.sagepub.com/doi/10.1177/0284185118759708

Matondang S , Ekawati A , Andrijono , et al . Minimal apparent diffusion coefficient value of the solid component to differentiate borderline and malignant ovarian epithelial tumours: a preliminary report . Pol J Radiol 2020 ; 85 : e250 - e253 . doi: 10.5114/pjr.2020.95921 1001-9294-36-3-196/pjr.2020.95921 . DOI: 10.5114/pjr.2020.95921 http://doi.org/10.5114/pjr.2020.95921

Mimura R , Kato F , Tha KK , et al . Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components . Jpn J Radiol 2016 ; 34 ( 3 ): 229 - 37 . doi: 10.1007/s11604-016-0518-6 1001-9294-36-3-196/s11604-016-0518-6 . DOI: 10.1007/s11604-016-0518-6 http://doi.org/10.1007/s11604-016-0518-6

Lee JM , Minasian L , Kohn EC . New strategies in ovarian cancer treatment . Cancer 2019 ; 125 Suppl 24: 4623 - 9 . doi: 10.1002/cncr.32544 1001-9294-36-3-196/cncr.32544 . DOI: 10.1002/cncr.32544 http://doi.org/10.1002/cncr.32544 https://onlinelibrary.wiley.com/toc/10970142/125/S24 https://onlinelibrary.wiley.com/toc/10970142/125/S24

Tothill RW , Tinker AV , George J , et al . Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome . Clin Cancer Res 2008 ; 14 ( 16 ): 5198 - 208 . doi: 10.1158/1078-0432.CCR-08-0196 1001-9294-36-3-196/1078-0432.CCR-08-0196 . DOI: 10.1158/1078-0432.CCR-08-0196 http://doi.org/10.1158/1078-0432.CCR-08-0196 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-08-0196 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-08-0196

Akazawa M , Hashimoto K . Artificial intelligence in ovarian cancer diagnosis . Anticancer Res 2020 ; 40 ( 8 ): 4795 - 800 . doi: 10.21873/anticanres.14482 1001-9294-36-3-196/anticanres.14482 . DOI: 10.21873/anticanres.14482 http://doi.org/10.21873/anticanres.14482 http://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.14482 http://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.14482

Zhang H , Mao Y , Chen X , et al . Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study . Eur Radiol 2019 ; 29 ( 7 ): 3358 - 71 . doi: 10.1007/s00330-019-06124-9 1001-9294-36-3-196/s00330-019-06124-9 . DOI: 10.1007/s00330-019-06124-9 http://doi.org/10.1007/s00330-019-06124-9

Anastasi E , Gigli S , Ballesio L , et al . The Complementary role of imaging and tumor biomarkers in gynecological cancers: an update of the literature . Asian Pac J Cancer Prev 2018 ; 19 ( 2 ): 309 - 17 . doi: 10.22034/APJCP.2018.19.2.309 1001-9294-36-3-196/APJCP.2018.19.2.309 . DOI: 10.22034/APJCP.2018.19.2.309 http://doi.org/10.22034/APJCP.2018.19.2.309

Qian L , Ren J , Liu A , et al . MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes . Eur Radiol 2020 ; 30 ( 11 ): 5815 - 25 . doi: 10.1007/s00330-020-06993-5 1001-9294-36-3-196/s00330-020-06993-5 . DOI: 10.1007/s00330-020-06993-5 http://doi.org/10.1007/s00330-020-06993-5 https://doi.org/10.1007/s00330-020-06993-5 https://doi.org/10.1007/s00330-020-06993-5

Takaya H , Nakai H , Sakai K , et al . Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course . Gynecol Oncol 2020 ; 156 ( 2 ): 415 - 22 . doi: 10.1016/j.ygyno.2019.11.013 1001-9294-36-3-196/j.ygyno.2019.11.013 . DOI: 10.1016/j.ygyno.2019.11.013 http://doi.org/10.1016/j.ygyno.2019.11.013 https://linkinghub.elsevier.com/retrieve/pii/S0090825819316646 https://linkinghub.elsevier.com/retrieve/pii/S0090825819316646

Bodelon C , Killian JK , Sampson JN , et al . Molecular classification of epithelial ovarian cancer based on methylation profiling: evidence for survival heterogeneity . Clin Cancer Res 2019 ; 25 ( 19 ): 5937 - 46 . doi: 10.1158/1078-0432.CCR-18-3720 1001-9294-36-3-196/1078-0432.CCR-18-3720 . DOI: 10.1158/1078-0432.CCR-18-3720 http://doi.org/10.1158/1078-0432.CCR-18-3720

Macintyre G , Goranova TE , De Silva D , et al . Copy number signatures and mutational processes in ovarian carcinoma . Nat Genet 2018 ; 50 ( 9 ): 1262 - 70 . doi: 10.1038/s41588-018-0179-8 1001-9294-36-3-196/s41588-018-0179-8 . DOI: 10.1038/s41588-018-0179-8 http://doi.org/10.1038/s41588-018-0179-8

Jimenez-Sanchez A , Memon D , Pourpe S , et al . Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient . Cell 2017 ; 170 ( 5 ): 927 - 38 . doi: 10.1016/j.cell.2017.07.025 1001-9294-36-3-196/j.cell.2017.07.025 . DOI: 10.1016/j.cell.2017.07.025 http://doi.org/10.1016/j.cell.2017.07.025 https://linkinghub.elsevier.com/retrieve/pii/S0092867417308322 https://linkinghub.elsevier.com/retrieve/pii/S0092867417308322

Gillies RJ , Kinahan PE , Hricak H . Radiomics: images are more than pictures, they are data . Radiology 2016 ; 278 ( 2 ): 563 - 77 . doi: 10.1148/radiol.2015151169 1001-9294-36-3-196/radiol.2015151169 . DOI: 10.1148/radiol.2015151169 http://doi.org/10.1148/radiol.2015151169

Beer L , Martin-Gonzalez P , Delgado-Ortet M , et al . Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer . Eur Radiol 2021 ; 31 ( 6 ): 3765 - 72 . doi: 10.1007/s00330-020-07560-8 1001-9294-36-3-196/s00330-020-07560-8 . DOI: 10.1007/s00330-020-07560-8 http://doi.org/10.1007/s00330-020-07560-8 https://doi.org/10.1007/s00330-020-07560-8 https://doi.org/10.1007/s00330-020-07560-8

Forstner R , Sala E , Kinkel K , et al . ESUR guidelines: ovarian cancer staging and follow-up . Eur Radiol 2010 ; 20 ( 12 ): 2773 - 80 . doi: 10.1007/s00330-010-1886-4 1001-9294-36-3-196/s00330-010-1886-4 . DOI: 10.1007/s00330-010-1886-4 http://doi.org/10.1007/s00330-010-1886-4 http://link.springer.com/10.1007/s00330-010-1886-4 http://link.springer.com/10.1007/s00330-010-1886-4

Javadi S , Ganeshan DM , Qayyum A , et al . Ovarian cancer, the revised FIGO staging system, and the role of imaging . AJR Am J Roentgenol 2016 ; 206 ( 6 ): 1351 - 60 . doi: 10.2214/AJR.15.15199 1001-9294-36-3-196/AJR.15.15199 . DOI: 10.2214/AJR.15.15199 http://doi.org/10.2214/AJR.15.15199 http://www.ajronline.org/doi/10.2214/AJR.15.15199 http://www.ajronline.org/doi/10.2214/AJR.15.15199

Michielsen K , Vergote I , Op DBK , et al . Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT . Eur Radiol 2014 ; 24 ( 4 ): 889 - 901 . doi: 10.1007/s00330-013-3083-8 1001-9294-36-3-196/s00330-013-3083-8 . DOI: 10.1007/s00330-013-3083-8 http://doi.org/10.1007/s00330-013-3083-8

Nougaret S , Addley HC , Colombo PE , et al . Ovarian carcinomatosis: how the radiologist can help plan the surgical approach . Radiographics 2012 ; 32 ( 6 ): 1775 - 800 , 1800 - 03 . doi: 10.1148/rg.326125511 1001-9294-36-3-196/rg.326125511 . DOI: 10.1148/rg.326125511 http://doi.org/10.1148/rg.326125511 http://pubs.rsna.org/doi/10.1148/rg.326125511 http://pubs.rsna.org/doi/10.1148/rg.326125511

Solass W , Horvath P , Struller F , et al . Functional vascular anatomy of the peritoneum in health and disease . Pleura Peritoneum 2016 ; 1 ( 3 ): 145 - 58 . doi: 10.1515/pp-2016-0015 1001-9294-36-3-196/pp-2016-0015 . DOI: 10.1515/pp-2016-0015 http://doi.org/10.1515/pp-2016-0015 https://www.degruyter.com/document/doi/10.1515/pp-2016-0015/html https://www.degruyter.com/document/doi/10.1515/pp-2016-0015/html

Sehouli J , Grabowski JP . Surgery in recurrent ovarian cancer . Cancer 2019 ; 125 Suppl 24: 4598 - 601 . doi: 10.1002/cncr.32511 1001-9294-36-3-196/cncr.32511 . DOI: 10.1002/cncr.32511 http://doi.org/10.1002/cncr.32511

Song XL , Ren JL , Yao TY , et al . Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer . Eur Radiol 2021 ; E-pub: May 4 , 2021 . doi: 10.1007/s00330-021-08004-7 1001-9294-36-3-196/s00330-021-08004-7 . DOI: 10.1007/s00330-021-08004-7 http://doi.org/10.1007/s00330-021-08004-7

Ai Y , Zhang J , Jin J , et al . Preoperative prediction of metastasis for ovarian cancer based on computed tomography radiomics features and clinical fact-ors . Front Oncol 2021 ; 11 : 610742 . doi: 10.3389/fonc.2021.610742 1001-9294-36-3-196/fonc.2021.610742 . DOI: 10.3389/fonc.2021.610742 http://doi.org/10.3389/fonc.2021.610742 https://www.frontiersin.org/articles/10.3389/fonc.2021.610742/full https://www.frontiersin.org/articles/10.3389/fonc.2021.610742/full

Siegel RL , Miller KD , Fuchs HE , et al . Cancer statistics, 2021 . CA Cancer J Clin 2021 ; 71 ( 1 ): 7 - 33 . doi: 10.3322/caac.21654 1001-9294-36-3-196/caac.21654 . DOI: 10.3322/caac.21654 http://doi.org/10.3322/caac.21654 https://onlinelibrary.wiley.com/toc/15424863/71/1 https://onlinelibrary.wiley.com/toc/15424863/71/1

Rambau PF , Vierkant RA , Intermaggio MP , et al . Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an ovarian tumor tissue analysis consortium study . J Pathol Clin Res 2018 ; 4 ( 4 ): 250 - 61 . doi: 10.1002/cjp2.109 1001-9294-36-3-196/cjp2.109 . DOI: 10.1002/cjp2.109 http://doi.org/10.1002/cjp2.109 https://onlinelibrary.wiley.com/toc/20564538/4/4 https://onlinelibrary.wiley.com/toc/20564538/4/4

Parkinson CA , Gale D , Piskorz AM , et al . Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma: a retrospective study . PLoS Med 2016 ; 13 ( 12 ): e1002198 . doi: 10.1371/journal.pmed.1002198 1001-9294-36-3-196/journal.pmed.1002198 . DOI: 10.1371/journal.pmed.1002198 http://doi.org/10.1371/journal.pmed.1002198 https://dx.plos.org/10.1371/journal.pmed.1002198 https://dx.plos.org/10.1371/journal.pmed.1002198

Schwarz RF , Ng CK , Cooke SL , et al . Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis . PLoS Med 2015 ; 12 ( 2 ): e1001789 . doi: 10.1371/journal.pmed.1001789 1001-9294-36-3-196/journal.pmed.1001789 . DOI: 10.1371/journal.pmed.1001789 http://doi.org/10.1371/journal.pmed.1001789 https://dx.plos.org/10.1371/journal.pmed.1001789 https://dx.plos.org/10.1371/journal.pmed.1001789

Lu H , Arshad M , Thornton A , et al . A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer . Nat Commun 2019 ; 10 ( 1 ): 764 . doi: 10.1038/s41467-019-08718-9 1001-9294-36-3-196/s41467-019-08718-9 . DOI: 10.1038/s41467-019-08718-9 http://doi.org/10.1038/s41467-019-08718-9 https://doi.org/10.1038/s41467-019-08718-9 https://doi.org/10.1038/s41467-019-08718-9

Meier A , Veeraraghavan H , Nougaret S , et al . Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer . Abdom Radiol (NY) 2019 ; 44 ( 6 ): 2040 - 7 . doi: 10.1007/s00261-018-1840-5 1001-9294-36-3-196/s00261-018-1840-5 . DOI: 10.1007/s00261-018-1840-5 http://doi.org/10.1007/s00261-018-1840-5

Zargari A , Du Y , Heidari M , et al . Prediction of chemotherapy response in ovarian cancer patients using a new clustered quantitative image marker . Phys Med Biol 2018 ; 63 ( 15 ): 155020 . doi: 10.1088/1361-6560/aad3ab 1001-9294-36-3-196/1361-6560/aad3ab . DOI: 10.1088/1361-6560/aad3ab http://doi.org/10.1088/1361-6560/aad3ab https://iopscience.iop.org/article/10.1088/1361-6560/aad3ab https://iopscience.iop.org/article/10.1088/1361-6560/aad3ab

Rizzo S , Botta F , Raimondi S , et al . Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months . Eur Radiol 2018 ; 28 ( 11 ): 4849 - 59 . doi: 10.1007/s00330-018-5389-z 1001-9294-36-3-196/s00330-018-5389-z . DOI: 10.1007/s00330-018-5389-z http://doi.org/10.1007/s00330-018-5389-z https://doi.org/10.1007/s00330-018-5389-z https://doi.org/10.1007/s00330-018-5389-z

Wei W , Rong Y , Liu Z , et al . Radiomics: a novel CT-based method of predicting postoperative recurrence in ovarian cancer . Annu Int Conf IEEE Eng Med Biol Soc 2018 ; 2018 : 4130 - 33 . doi: 10.1109/EMBC.2018.8513351 1001-9294-36-3-196/EMBC.2018.8513351 . DOI: 10.1109/EMBC.2018.8513351 http://doi.org/10.1109/EMBC.2018.8513351

Vargas HA , Veeraraghavan H , Micco M , et al . A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome . Eur Radiol 2017 ; 27 ( 9 ): 3991 - 4001 . doi: 10.1007/s00330-017-4779-y 1001-9294-36-3-196/s00330-017-4779-y . DOI: 10.1007/s00330-017-4779-y http://doi.org/10.1007/s00330-017-4779-y http://link.springer.com/10.1007/s00330-017-4779-y http://link.springer.com/10.1007/s00330-017-4779-y

Wang S , Liu Z , Rong Y , et al . Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer . Radiother Oncol 2019 ; 132 : 171 - 7 . doi: 10.1016/j.radonc.2018.10.019 1001-9294-36-3-196/j.radonc.2018.10.019 . DOI: 10.1016/j.radonc.2018.10.019 http://doi.org/10.1016/j.radonc.2018.10.019 https://linkinghub.elsevier.com/retrieve/pii/S0167814018335436 https://linkinghub.elsevier.com/retrieve/pii/S0167814018335436

Views

939

Downloads

CSCD

Alert me when the article has been cited

Submit

Publicity Resources

Histopathological Diagnosis System for Gastritis Using Deep Learning Algorithm

Collaborations of Industry, Academia, Research and Application Improve the Healthy Development of Medical Imaging Artificial Intelligence Industry in China

The Artificial Intelligence-Enabled Medical Imaging: Today and Its Future

Artificial Intelligence in Healthcare and Medicine: Promises, Ethical Challenges and Governance

Intelligent Electrocardiogram Analysis in Medicine: Data, Methods, and Applications

Related Author

Liu Cancheng

Wang Shuhao

Ba Wei

Wang Yuefeng

Shi Huaiyin

Song Zhigang

Liu Shiyuan

Xiao Yi

Related Institution

Department of Pathology, Chinese PLA General Hospital & Medical School

Artificial Intelligence Lab, Thorough Images

海军军医大学长征医院放射科

State Key Laboratory for Novel Software Technology, Nanjing University

Institute for Medical Imaging Technology, School of Biomedical Engineering, Shanghai Jiao Tong University

⁰